It was recently shown that the detectability of cMyBPC3 in control plasma samples was superior to that of hs-cTnT, suggesting that MyBPC3 might be a better biomarker for detecting dormant cardiac disease, and this deserves future attention [71]. This evidence concerns the gene TNNT2 and heart disorder.